Lung Cancer Management in 2010ByApar Kishor Ganti, MD, MS,Chao H. Huang, MD,Mark A. Klein, MD,Sean Keefe, PharmD,Michael J. Kelley, MDPublished: January 15th 2011 | Updated: November 11th 2020Exciting advances in understanding the biology of lung cancer have occurred over the last few years.
Autocrine Growth Factors and Neuroendocrine Markers in the Development of Small-Cell Lung CancerByBruce E. Johnson, MD,Michael J. Kelley, MDPublished: January 2nd 1997 | Updated: November 11th 2020Two different clinical trials using biological agents directed against an autocrine growth factor and a surface marker of neuroendocrine differentiation have been used for patients with relapsed small-cell lung cancer. In a
